Dermatology clinical trials recruiting in Florida

59 recruiting dermatology trials match in Florida. Showing 20.

• Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic ArthritisRecruiting

  Phase 2 · AbbVie · Avon Park, Florida

• A Study Evaluating BFB759 in Moderate to Severe Hidradenitis SuppurativaRecruiting

  Phase 2 / Phase 3 · Bluefin Biomedicine, Inc. · Boca Raton, Florida

• A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabRecruiting

  Phase 3 · AbbVie · Hollywood, Florida

• Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque PsoriasisRecruiting

  Phase 2 · Oruka Therapeutics, Inc. · Miami, Florida

• A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic ArthritisRecruiting

  Phase 3 · Janssen Research & Development, LLC · Clearwater, Florida

• Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Recruiting

  Phase 2 · Merck Sharp & Dohme LLC · Aventura, Florida

• Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild AcneRecruiting

  Phase 1 / Phase 2 · Sanofi Pasteur, a Sanofi Company · Brandon, Florida

• A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic DermatitisRecruiting

  Phase 2 · Janssen Research & Development, LLC · São Paulo

• A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsRecruiting

  Phase 1 · UCB Biopharma SRL · Ormond Beach, Florida

• A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque PsoriasisRecruiting

  Phase 4 · Bausch Health Americas, Inc. · Doral, Florida

• A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)Recruiting

  Phase 4 · Eli Lilly and Company · Kissimmee, Florida

• A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic DermatitisRecruiting

  Phase 3 · AbbVie · Coral Gables, Florida

• A Study of Zasocitinib in Adults With Nonsegmental VitiligoRecruiting

  Phase 2 · Takeda · Boynton Beach, Florida

• A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic DermatitisRecruiting

  Phase 2 · UCB Biopharma SRL · Boca Raton, Florida

• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar PustulosisRecruiting

  Phase 3 · UCB Biopharma SRL · Coral Gables, Florida

• A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque PsoriasisRecruiting

  Phase 2 · InventisBio Co., Ltd · Birmingham, Alabama

• A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic DermatitisRecruiting

  Phase 3 · Organon and Co · Boca Raton, Florida

• Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo PatientsRecruiting

  Phase 2 · Elixiron Immunotherapeutics (Hong Kong) Ltd. · Hollywood, Florida

• A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic ArthritisRecruiting

  Phase 2 · Janssen Research & Development, LLC · Cutler Bay, Florida

• Guselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsRecruiting

  Phase 3 · University of Pennsylvania · Loxahatchee Groves, Florida

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.